ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug RP-001 enters human trials for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called RP-001 in 66 adults with advanced solid tumors, including colorectal and pancreatic cancers. The main goal is to check safety and find the best dose. Researchers will also watch for any signs that the drug shrinks tumors.
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Recurv Pharma Inc • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
New hope for advanced myeloma: pfizer launches early trial
Disease control Not yet recruitingThis early-stage study tests a new drug, PF-07994525, in 120 adults with advanced multiple myeloma that has returned or not responded to treatment. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. The study has two parts: first, find…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
New study checks cancer Drug's effect on common medications
Knowledge-focused Not yet recruitingThis study looks at how a cancer drug called pelabresib changes the way the body processes other drugs. It involves 24 adults with advanced cancers who have no standard treatment options. Participants will take pelabresib along with other medicines to measure drug levels in the b…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 04:30 UTC